Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel bought 2,500 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were purchased at an average price of $19.98 per share, for a total transaction of $49,950.00. Following the purchase, the chief executive officer now owns 5,347,777 shares in […]
Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel acquired 12,700 shares of the stock in a transaction on Thursday, February 15th. The stock was bought at an average price of $11.07 per share, with a total value of $140,589.00. Following the completion of the acquisition, the chief executive officer now directly owns […]
Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel acquired 12,700 shares of the firm’s stock in a transaction dated Thursday, February 15th. The shares were purchased at an average cost of $11.07 per share, for a total transaction of $140,589.00. Following the acquisition, the chief executive officer now directly owns 5,325,377 shares […]
Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) was the target of a large decline in short interest in June. As of June 30th, there was short interest totalling 195,500 shares, a decline of 12.7% from the June 15th total of 224,000 shares. Approximately 3.3% of the company’s stock are short sold. Based on an […]